Sign In

Andrew ElBardissi, MD

Partner at Deerfield Management

Andrew ElBardissi, MD, is a prominent figure in the healthcare investment sector, currently serving as a Board Member at Medical Microinstruments, Inc. since June 2022. He is also a Partner at Deerfield Management, where he has been instrumental in focusing on structured transactions within the firm's Private Design Funds since 2017. His extensive board experience includes positions at various innovative healthcare companies such as Aurion Biotech, Bitteroot, and Epic Sciences, among others.123

Educational Background

  • Doctor of Medicine (M.D.) from Mayo Medical School.
  • Master of Public Health (M.P.H.) in Quantitative Methods from Harvard University.
  • Master of Business Administration (MBA) from Harvard Business School.
  • Bachelor of Science (B.S.) with honors in Biology from the Schreyer Honors College at Pennsylvania State University.12

Professional Experience

ElBardissi's career has spanned various roles:

  • Healthcare Investment Banking Associate at J.P. Morgan, where he led significant transactions in biotech and medical technology.
  • Cardiothoracic Surgery Resident at Stanford University School of Medicine and General Surgery Resident at Brigham and Women's Hospital affiliated with Harvard Medical School.123

He has a strong research background, having received independent funding for projects aimed at improving patient safety in cardiac surgery and has published over 30 articles in peer-reviewed journals.23

Contributions to Medical Microinstruments

At Medical Microinstruments, ElBardissi plays a crucial role in advancing robotic microsurgery technologies. He has expressed enthusiasm about the potential of the company's Symani Surgical System to transform microsurgical procedures, emphasizing its capability to enhance surgical precision and improve patient outcomes.3

Highlights

Jul 6 · salesflow.io
Andrew ElBardissi, MD – Partner – Salesflow – LinkedIn Automation ...
Mar 4 · theorg.com
Andrew Elbardissi - Board Member at Pleno Inc. | The Org
Jun 21 · Pulse 2.0
Bitterroot Bio: $145 Million Raised For Developing Transformative Medicines in Cardio-Immunology - Pulse 2.0
Bitterroot Bio: $145 Million Raised For Developing Transformative Medicines in Cardio-Immunology - P
Jun 7 · Yahoo Finance
Bitterroot Bio Launches Out of Stealth with $145 Million Series A Financing to Develop Transformative Medicines in Cardio-immunology - Yahoo Finance
Bitterroot Bio Launches Out of Stealth with $145 Million Series A Financing to Develop Transformativ
Jul 25 · robotics247.com
Medical Microinstruments Secures $75M to Advance Robotic ...

Related Questions

What are Andrew ElBardissi's main responsibilities at Deerfield Management?
How did Andrew ElBardissi transition from cardiothoracic surgery to investment banking?
What are some notable deals Andrew ElBardissi has worked on at Deerfield Management?
How does Andrew ElBardissi's background in medicine influence his work in the biotech industry?
What are the key achievements of Andrew ElBardissi in his career so far?
Andrew ElBardissi, MD
Andrew ElBardissi, MD, photo 1
Andrew ElBardissi, MD, photo 2
Add to my network

Location

New York, New York, United States